Staar Surgical Co (STAA): Richard A Meier , director of Staar Surgical Co sold 25,000 shares on May 19, 2016. The Insider selling transaction was reported by the company on May 23, 2016 to the Securities and Exchange Commission. The shares were sold at $5.34 per share for a total value of $133,849.33 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Aug 26, 2015, Caren L Mason (CEO) purchased 10,000 shares at $7.34 per share price.On Aug 11, 2015, Lou Silverman (director) purchased 1,500 shares at $8.18 per share price.Also, On Aug 7, 2015, Jack Steven Roush (director) purchased 1,000 shares at $8.08 per share price.On Apr 7, 2015, Samuel J Gesten (VP, General Counsel) sold 3,223 shares at $7.14 per share price.
STAAR Surgical Company: On Friday, May 20, 2016 heightened volatility was witnessed in STAAR Surgical Company which led to swings in the share price. The shares opened for trading at $5.37 and hit $5.49 on the upside , eventually ending the session at $5.34, with a gain of 0.19% or 0.01 points. The heightened volatility saw the trading volume jump to 97,455 shares. The 52-week high of the share price is $10.76 and the company has a market cap of $214,599 M . The 52-week low of the share price is at $4.98.
Company has been under the radar of several Street Analysts.STAAR Surgical Company is Upgraded by The Benchmark Company to Buy and the brokerage firm has set the Price Target at $6. Earlier the firm had a rating of Hold on the company shares. The Rating was issued on May 18, 2016.
STAAR Surgical Company designs develops manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company’s principal products are intraocular lenses (IOLs) and implantable Collamer lenses (ICLs). IOLs are prosthetic intraocular lenses used to restore vision that has been adversely affected by cataracts and include the Company’s lines of silicone and Collamer IOLs and the Preloaded Injector (a silicone or acrylic IOL preloaded into a single-use disposable injector). ICLs consisting of the Company’s ICL and Toric implantable collamer lenses (TICL) are intraocular lenses used to correct refractive conditions such as myopia (near-sightedness) hyperopia (far-sightedness) and astigmatism. The Company operates under the brands STAAR Visian Collamer CentraFLOW AquaPORT nanoFLEX nanoPOINT Epiphany and AquaFlow. Collamer is the brand name for its collagen copolymer lens material.